This inventor holds 51 USPTO granted patents and 37 published patent applications, plus 12 CIPO patents and 19 EPO patents, primarily in Antibody Drug Conjugates. Top assignees: Genentech, Inc., Seattle Genetics, Inc., Esoterix, Inc.. Active years: 1999-2025.
Location History:
- South San Francisco, CA (US) (2006)
- San Carlos, CA (US) (1999 - 2020)
Company Filing History:
45 out of 3,294 
4 out of 132 
1 out of 4 
Years Active: 1999-2025
Areas of Expertise:
Title: Unveiling the Genius of Mark X Sliwkowski: A Pioneer in Antibody Drug Conjugates
Introduction: Meet Mark X Sliwkowski, a distinguished inventor based in San Carlos, CA (US) known for his groundbreaking work in the field of antibody drug conjugates. With an impressive portfolio of 49 patents, Sliwkowski has significantly contributed to the advancements in pharmaceutical science.
Latest Patents: Sliwkowski's latest patents revolve around Pyrrolobenzodiazepine antibody drug conjugates and methods of use. These inventions entail the development of antibody-drug conjugates that combine antibodies with a pyrrolobenzodiazepine drug moiety via a disulfide linker. The innovative methods outlined in these patents showcase Sliwkowski's commitment to revolutionizing targeted drug delivery in cancer therapy.
Career Highlights: Throughout his career, Sliwkowski has worked with renowned companies such as Genentech, Inc. and Seattle Genetics, Inc. His tenure at these esteemed organizations has served as a testament to his expertise in the biopharmaceutical industry. By spearheading research and development initiatives, Sliwkowski has played a pivotal role in shaping the future of precision medicine.
Collaborations: Sliwkowski has collaborated closely with industry experts such as Thomas Pillow and Allen J Ebens. Their collective efforts have led to the successful implementation of novel drug delivery systems and therapeutic approaches. By fostering a collaborative environment, Sliwkowski has fostered innovation and driven scientific progress in his field.
Conclusion: In conclusion, Mark X Sliwkowski stands out as a visionary inventor who continues to push the boundaries of pharmaceutical innovation. His relentless pursuit of excellence and his dedication to improving patient outcomes underscore his invaluable contributions to the field of antibody drug conjugates. As Sliwkowski's impact reverberates throughout the industry, his legacy as a trailblazing inventor remains unmatched.